These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The Human Genome Project in the United States: a perspective on the commercial, ethical, legislative and health care issues. Mackler BF; Barach M J Int Bioethique; 1991; 2(3):149-57. PubMed ID: 11654898 [TBL] [Abstract][Full Text] [Related]
5. Interaction between anesthesia technology innovators, manufacturers, and purchasers. Gingles B Anesthesiol Clin; 2008 Dec; 26(4):785-92, viii. PubMed ID: 19041629 [TBL] [Abstract][Full Text] [Related]
6. The parting of the ways? How biomaterials may differ from advanced materials in the next century. Williams D Med Device Technol; 1999 May; 10(4):8-11. PubMed ID: 10539111 [TBL] [Abstract][Full Text] [Related]
7. Sociology of pharmaceuticals development and regulation: a realist empirical research programme. Abraham J Sociol Health Illn; 2008 Sep; 30(6):869-85. PubMed ID: 18761508 [TBL] [Abstract][Full Text] [Related]
8. The business of demographics. Russell C Popul Bull; 1984 Jun; 39(3):1-40. PubMed ID: 12313263 [TBL] [Abstract][Full Text] [Related]
9. Triage in the nation's medicine cabinet: the puzzling scarcity of vaccines and other drugs. Noah L S C Law Rev; 2002; 54(2):371-403. PubMed ID: 15156891 [TBL] [Abstract][Full Text] [Related]
10. The changing environment for technological innovation in health care. Goodman CS; Gelijns AC Baxter Health Policy Rev; 1996; 2():267-315. PubMed ID: 11066263 [TBL] [Abstract][Full Text] [Related]
11. Prospects for application of biotechnology-derived biomaterials. Hellman KB; Picciolo GL; Fox CF J Cell Biochem; 1994 Oct; 56(2):210-24. PubMed ID: 7829583 [No Abstract] [Full Text] [Related]
12. The important role of material and chemical characterisation in device evaluation. Albert DE Med Device Technol; 2004 Jun; 15(5):15-8. PubMed ID: 15285481 [TBL] [Abstract][Full Text] [Related]
13. Exploring opportunities for collaboration between the corporate sector and the dental education community. Alexander D; Clarkson J; Buchanan R; Chadwick G; Chesters R; Drisko CL; Douglass CW; Farrell L; Fletcher K; Makoni F; Monaco M; Nordquist B; Park NI; Riggs S; Schou L; Smales FC; Stamm JW; Toh CG; Volpe T; Ward P; Warren P Eur J Dent Educ; 2008 Feb; 12 Suppl 1():64-73. PubMed ID: 18289269 [TBL] [Abstract][Full Text] [Related]
14. Some philosophies for standardizations of biomaterials and related devices. Yokobori T Biomed Mater Eng; 1994; 4(4):341-3. PubMed ID: 7950882 [TBL] [Abstract][Full Text] [Related]
16. Considering experimentation and elusive truth: informed consent made difficult. Brodeur D Issues (St Louis Mo); 1992; 7(2):1-8. PubMed ID: 11659444 [No Abstract] [Full Text] [Related]
17. A new public/private partnership in the interest of public health. Barlow WK Food Drug Law J; 1999; 54(3):363-6. PubMed ID: 11797703 [No Abstract] [Full Text] [Related]
18. A survey of developments in food and drug law from July 1998 to November 1999. Littlefield N; Hada NR Food Drug Law J; 2000; 55(1):35-56. PubMed ID: 12296348 [No Abstract] [Full Text] [Related]
19. Introductory remarks to the biotechnology applications in biomaterials workshop. Burlington DB J Cell Biochem; 1994 Oct; 56(2):145-6. PubMed ID: 7829570 [No Abstract] [Full Text] [Related]
20. Allied against reform: pharmaceutical industry-academic physician relations in the United States, 1945-1970. Tobbell DA Bull Hist Med; 2008; 82(4):878-912. PubMed ID: 19075387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]